Live Demo: This is a live DrugChatter demonstration using real AI-generated drug queries and analysis. Want to see how your drug is represented by AI? Contact DrugChatter

keytruda

Brand Visibility Tracking

How this brand shows up in AI chatbot answers — presence, position, sentiment, and how it stacks up against competitors.

Last checked: Aug 15, 2026

–

Score / 100

Latest check

Weighted composite of presence, position, sentiment, and recommendation strength across tracked prompts.

Presence

–

Avg. position

–

Lower is better

Sentiment

–

Recommendation mix — latest check

How the brand was framed across the latest tracked prompts.

Competitive landscape — latest check

Visibility vs. sentiment. Bubble size reflects rank position (bigger = higher-ranked).

Best known for — latest check

In many cancer types/settings, both drugs are considered similarly effective overall

Best-supported indication for your exact cancer type/stage

PD‑L1–based selection

Core Claims — latest check

Keytruda is the brand name for pembrolizumab, a monoclonal antibody that targets PD-1.

Keytruda does not have a true 'generic' (antibodies like pembrolizumab aren’t approved as simple generics).

Brand-name Keytruda

Head-to-head trials generally show similar overall effectiveness, not a clear universal win for Keytruda.

Cross-trial comparisons and indirect evidence can be misleading.

Differentiators — latest check

Drug/structure: pembrolizumab and nivolumab are different antibodies, even though both target PD-1.

Trial evidence and indications: they overlap in some cancers, but each has its own FDA/EMA-labeled indications, line of therapy, and combination partners.

Dosing schedules: schedules can differ (e.g., q3 weeks vs q2/3 weeks depending on the regimen and country/label).

Side-effect profile: they’re broadly similar (immune-related adverse events).

Effectiveness varies by cancer type and endpoint.

Competitor comparison — latest check

Brand	Visibility	Sentiment	Position	Recommended

30-day composite trends

Score

Overall composite score, per day.

Visibility vs. sentiment

Two lenses on the same conversations — how much the brand shows up, and how it's spoken about.

Average rank position

Where the brand lands among all brands mentioned, in reading order. Lower is better.

Recent checks

Date	Score	Visibility	Position	Sentiment
Aug 12, 2026	58	66	1	53
Aug 14, 2026	66	68	1	55
Aug 15, 2026	62	62	1	52